Bellevue Group’s Procept Biorobotics PRCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28.2M | Buy |
489,278
+74,355
| +18% | +$4.28M | 0.62% | 42 |
|
|
2025
Q1 | $24.2M | Sell |
414,923
-47,971
| -10% | -$2.79M | 0.54% | 46 |
|
|
2024
Q4 | $37.3M | Sell |
462,894
-149,797
| -24% | -$12.1M | 0.72% | 31 |
|
|
2024
Q3 | $49.1M | Sell |
612,691
-56,358
| -8% | -$4.52M | 0.8% | 32 |
|
|
2024
Q2 | $40.9M | Sell |
669,049
-221,065
| -25% | -$13.5M | 0.66% | 40 |
|
|
2024
Q1 | $44M | Buy |
890,114
+4,768
| +0.5% | +$236K | 0.67% | 47 |
|
|
2023
Q4 | $37.1M | Sell |
885,346
-2,950
| -0.3% | -$124K | 0.57% | 55 |
|
|
2023
Q3 | $29.1M | Buy |
888,296
+146,779
| +20% | +$4.82M | 0.47% | 64 |
|
|
2023
Q2 | $26.2M | Hold |
741,517
| – | – | 0.37% | 67 |
|
|
2023
Q1 | $21.1M | Hold |
741,517
| – | – | 0.31% | 79 |
|
|
2022
Q4 | $30.8M | Buy |
741,517
+152,255
| +26% | +$6.32M | 0.41% | 68 |
|
|
2022
Q3 | $24.4M | Sell |
589,262
-6,118
| -1% | -$254K | 0.35% | 76 |
|
|
2022
Q2 | $19.5M | Buy |
595,380
+309,305
| +108% | +$10.1M | 0.28% | 87 |
|
|
2022
Q1 | $10M | Buy |
286,075
+112,426
| +65% | +$3.93M | 0.12% | 105 |
|
|
2021
Q4 | $4.34M | Buy |
173,649
+23,649
| +16% | +$591K | 0.04% | 130 |
|
|
2021
Q3 | $5.72M | Buy |
+150,000
| New | +$5.72M | 0.06% | 128 |
|